Most of the data reported on CHEK2-associated BC are largely based on studies of protein-truncating variants, in particular the CHEK2 c.1100delC variant, which is found fairly frequently in Northern European populations (Yang et al., 2012). This evidence concerns the gene CHEK2 and breast cancer.